The pharmaceutical industry will undergo significant changes this summer. A set of standards for the identification of medicinal products (IDMP) from the European Medicines Agency (EMA) will take effect in July, requiring the whole industry to apply the terminologies released by EMA. The changes have raised many concerns regarding how
Author
Gearing up for pharma’s big change
Real-world evidence: time to put the personal into personalised healthcare
For once it seems I’m able to admire Angelina Jolie with my wife’s approval. You see, it was the discovery of the BRCA1 and BRCA2 genes, which are responsible for breast cancer, which inspired my wife to take an MSc in Science Communications. She wanted to take science out of